Latest Press Releases
AMCP In the News
AMCP applauds Senators Moore Capito (R-WV) and Shaheen (D-NH) and Congressmen Thompson (D-CA-5) and McKinley (R-WV-1) on the introduction of the bipartisan Access to Prescription Digital Therapeutics Act.
AMCP applauds Congressman Brett Guthrie on the introduction of the Pre-approval Information Exchange (PIE) Act of 2022.
Mark McClellan, MD, PhD, was recently named 2022 Steven G. Avey Award recipient. The Avey award recognizes a managed care leader for sustained, exemplary, and distinguished service to the practice of pharmacy.
AMCP congratulates Robert Califf, MD, MACC, on his appointment as Commissioner of the U.S. Food and Drug Administration.
AMCP has recently published a manuscript in the Journal of Managed Care + Specialty Pharmacy (JMCP) focusing on the significant role that health plans, managed care organizations, prescribers, pharmacists, patients, and others have in decreasing the morbidity and mortality associated with opioid overdose.
AMCP announces the election of four members to the AMCP Board of Directors for the 2022-2023 term.
New principles promote the use of pay-for-performance arrangements that lead to improved patient outcomes.
Nearly 40 experts representing payers, pharmacy benefit managers, integrated delivery systems, patient advocates, academicians, and other key stakeholders in the managed care setting convened for AMCP’s Partnership Forum Addressing Evidence Gaps in the Expedited Review Process: Payer Perspectives.
AMCP signed onto an amicus brief in support of the OSHA Rule on COVID-19 Vaccination and Testing case in the U.S. Court of Appeals for the Sixth Circuit.
AMCP is pleased to announce that Jennifer S. Graff, PharmD, has joined the organization as senior director, professional affairs. Dr. Graff will lead strategic efforts for AMCP’s practice-related initiatives and work to advance patient outcomes and medication management strategies.
A group of 14 health care organizations in and around Washington, D.C. issued a joint statement making COVID vaccination a condition of returning to work in their respective offices.
Forum participants discussed various key components to better support appropriate and evidence-based coverage decisions for digital therapeutics.